Literature DB >> 16616610

Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.

Vannarat Saechan1, Atsumi Mori, Winyou Mitarnun, Wannapa Settheetham-Ishida, Takafumi Ishida.   

Abstract

BACKGROUND: The latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) has sequence heterogeneity. Some of the variants are associated with altered tumorigenic activity and show geographically specific localization. In Thailand, the EBV genome is frequently detected in circulating T cells of T-cell diseases.
OBJECTIVE: To determine the role of EBV LMP1 variation in the genesis of T-cell diseases, we focused on virus factors and analyzed EBV strains in Thailand. STUDY
DESIGN: EBV DNA was extracted from 18 healthy individuals and 45 patients with T-cell diseases in Southern Thailand and 30 healthy individuals in Central Thailand. By using PCR-direct sequencing method, nucleotide sequences corresponding to the carboxyl terminus of the LMP1 were determined.
RESULTS: Four known strains, B95-8 prototype, China 1, China 2 and Mediterranean (Med) and two novel strains, Southeast Asia 1 (SEA 1) and Southeast Asia 2 (SEA 2) were identified. The prevalence of China 2 strain was significantly different (p=0.006) between Central and Southern Thailand. Higher prevalence (p=0.026) of 30-bp deletion type in the Southern Thais was observed. The LMP1 Med strain was associated with the worse prognosis (p=0.029). Among T-cell diseases patients, CD3(+)-cell oriented infection was recognized in SEA1 strain (p=0.025).
CONCLUSION: The distribution of EBV strains may be associated with geographic/ethnic and clinical background in the Thai population. Certain EBV strains defined by their LMP1 sequence may influence cell tropism, disease association, or disease severity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616610     DOI: 10.1016/j.jcv.2006.01.018

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  10 in total

1.  Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.

Authors:  Mario Alejandro Lorenzetti; Magdalena Gantuz; Jaime Altcheh; Elena De Matteo; Paola Andrea Chabay; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 2.  Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children.

Authors:  Junhong Ai; Zhengde Xie; Chunyan Liu; Zhizuo Huang; Junmei Xu
Journal:  Virol J       Date:  2012-01-11       Impact factor: 4.099

Review 4.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

5.  Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.

Authors:  Do Nguyen-Van; Ingemar Ernberg; Ingemar Enrberg; Phi Phan-Thi Phi; Chinh Tran-Thi; LiFu Hu
Journal:  Virus Genes       Date:  2008-07-29       Impact factor: 2.332

6.  Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma.

Authors:  Susanna H Hutajulu; Eveline K Hoebe; Sandra Awm Verkuijlen; Jajah Fachiroh; Bambang Hariwijanto; Sofia M Haryana; Servi Jc Stevens; Astrid E Greijer; Jaap M Middeldorp
Journal:  Infect Agent Cancer       Date:  2010-09-19       Impact factor: 2.965

Review 7.  Epstein-barr virus sequence variation-biology and disease.

Authors:  Stelios Tzellos; Paul J Farrell
Journal:  Pathogens       Date:  2012-11-08

8.  Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar.

Authors:  Maria K Smatti; Hadi M Yassine; Raed AbuOdeh; Asmaa AlMarawani; Sara A Taleb; Asmaa A Althani; Gheyath K Nasrallah
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

Review 9.  Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.

Authors:  Maria K Smatti; Duaa W Al-Sadeq; Nadima H Ali; Gianfranco Pintus; Haissam Abou-Saleh; Gheyath K Nasrallah
Journal:  Front Oncol       Date:  2018-06-13       Impact factor: 6.244

10.  Comparison between presence of epstein barr virus in nodal and extra nodal diffuse large B cell lymphoma of head and neck, an Iranian experience.

Authors:  Mohammad Javad Ashraf; Alireza Makarempour; Ahmad Monabati; Negar Azarpira; Bijan Khademi; Afsoon Hakimzadeh; Elham Abedi; Bita Valibeigi
Journal:  Iran Red Crescent Med J       Date:  2012-12-06       Impact factor: 0.611

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.